Pneumocystis carinii (Pc) pneumonia is a common and lethal opportunistic infection in AIDS. Pc pneumonia is recurrent; when drug therapy is stopped, the Pc pneumonia recurs. Pc cysts are believed to play an important part in infection, activation and re-activation of the disease. A Beta 1->3 glucan forms the thick inner layer of Pc cyst walls. Purified cultured Pc organisms contain a very active Beta 1->3 D glucan synthase which is probably involved in the biosynthesis of the cell wall glucan. It is proposed to test the hypothesis that the addition of Beta 1->3 glucan cell wall inhibitors to conventional anti-Pc during therapy will alter or modulate the relapsing nature of the Pc infection. The Pc enzyme exhibiting Beta 1->3 D glucan synthase activity will be characterized. We will attempt to inhibit the Pc glucan synthase activity in vitro using members of several classes of inhibitors known to interfere with Beta 1->3 D glucan synthesis in other organisms. Suitable inhibitors will be selected from the in vitro study and will be studied in rats infected with Pc, in order to assess Pc cyst survival and disease recurrence. It is also proposed to clone the Pc synthase gene into E. coli and to express the gene product. This is a preliminary step for the eventual study of the control of cell wall synthesis in Pneumocystis carinii.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024194-06
Application #
3136986
Study Section
Special Emphasis Panel (ARR (V1))
Project Start
1987-09-30
Project End
1994-08-31
Budget Start
1992-09-01
Budget End
1994-08-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Koziel, H; Phelps, D S; Fishman, J A et al. (1998) Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol 18:834-43
Narasimhan, S; Armstrong, M; McClung, J K et al. (1997) Prohibitin, a putative negative control element present in Pneumocystis carinii. Infect Immun 65:5125-30
Narasimhan, S; Armstrong, M Y; Rhee, K et al. (1994) Gene for an extracellular matrix receptor protein from Pneumocystis carinii. Proc Natl Acad Sci U S A 91:7440-4
Williams, D J; Radding, J A; Dell, A et al. (1991) Glucan synthesis in Pneumocystis carinii. J Protozool 38:427-37
Armstrong, M Y; Smith, A L; Richards, F F (1991) Pneumocystis carinii pneumonia in the rat model. J Protozool 38:136S-138S
Armstrong, M Y; Koziel, H; Rose, R M et al. (1991) Indicators of Pneumocystis carinii viability in short-term cell culture. J Protozool 38:88S-90S
Radding, J A; Armstrong, M Y; Ullu, E et al. (1989) Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii. Infect Immun 57:2149-57